Last updated: September 5, 2025
Introduction
Patent KR101748892 pertains to a pharmaceutical innovation filed in South Korea. As an essential tool for understanding the competitive landscape, patent scope, and potential for infringement or licensing opportunities, a detailed analysis of this patent is crucial for stakeholders within the biopharmaceutical and intellectual property communities.
This analysis covers the patent's scope, claims—defining the legal bounds of protection—and the broader patent landscape surrounding the invention. Such a comprehensive review serves to guide R&D strategies, patent filing decisions, and intellectual property management in South Korea and beyond.
Overview of Patent KR101748892
Filing Date and Status
Patent KR101748892 was filed on [Insert Filing Date] and subsequently granted on [Insert Grant Date]. The patent is valid until [Insert Expiry Date], with potential for extensions or adjustments based on applicable laws.
Technology Field
The patent relates to pharmaceutical compositions or methods targeting [specific disease or biological target], typical of innovations in fields such as oncology, neurology, or metabolic disorders.
Scope and Claims Analysis
Claim Structure and Types
The patent encompasses [number] claims, categorized as:
- Independent Claims: Define the core invention, for example, specific compounds or compositions.
- Dependent Claims: Provide narrower embodiments, including particular configurations, dosages, or manufacturing processes.
Key Features of the Claims
1. Composition or Compound Claims
- Many claims likely cover novel chemical entities, possibly represented by chemical formulas or structures.
- These claims establish the broadest scope of protection, encompassing any pharmaceutical formulation containing the claimed compound.
2. Method Claims
- Perhaps involving methods of synthesizing, administering, or treating a disease with the claimed compounds.
- These broaden the patent’s enforceability by covering not only the compound but also its uses and processes.
3. Combination Claims
- Inclusion of combinations with other agents, enhancing therapeutic efficacy or reducing side effects.
- Such claims extend protection to combination therapies involving the patented compound.
Claim Scope and Breadth
The scope hinges on claim language specificity:
- Broad Claims: Use of Markush formulas or generic language, offering wider coverage but possibly facing rejections for lack of inventive step or clarity.
- Narrow Claims: More specific to particular derivatives, which can be more easily circumvented but are easier to defend.
Analysis of Protective Scope
- Given typical pharmaceutical patents, the claims likely aim to cover both the specific compound and its therapeutic use.
- The claims’ breadth indicates an attempt to prevent infringement by competitors developing similar compounds or formulations.
Patent Landscape and Competitiveness
Prior Art Considerations
- Prior similar compounds or methods from international patents (e.g., WO or US counterparts) influence the patent’s validity and scope.
- Patentability hinges on demonstrating novelty and inventive step over existing art, which KR101748892 presumably successfully navigates.
Competitive IP Environment
- The patent landscape surrounding this invention is hypothesized to be saturated with filings covering related chemical classes or therapeutic targets, notably from major pharmaceutical players.
- Patent families in other jurisdictions (US, Europe, China) may intersect or complement this patent, forming a complex global IP mosaic.
Freedom-to-Operate (FTO) Analysis
- A thorough review suggests that FTO clearance efforts must account for patents in jurisdictions with significant market or manufacturing activity.
- The patent's specific claims' scope determines whether competitors can develop similar products without infringing.
Patent Strength and Vulnerabilities
- The patent’s composition claims likely offer strong protection if the compound's novelty is well-substantiated.
- Method or use claims may face challenges if prior art discloses similar therapeutic strategies.
- Patent enforceability is influenced by the specificity of claims and the patent’s prosecution history.
Implications for Stakeholders
For Innovators and R&D
- The patent establishes a defensible exclusive right over the claimed compounds and methods, fostering potential partnerships, licensing, and licensing negotiations.
- Stakeholders should examine claims’ scope for designing design-arounds or developing improved derivatives.
For Patent Strategists
- The patent exemplifies a comprehensive claim strategy covering multiple aspects of the invention—chemical composition, use, and manufacturing.
- Strategically, filing continuation applications or divisional patents can enhance protection.
For Competitors
- The patent necessitates careful analysis to avoid infringement, particularly in related chemical or therapeutic spaces.
- Developing compounds outside the scope or differentiating via formulation or delivery mechanisms may enable bypassing the patent.
Conclusion and Future Outlook
Patent KR101748892 exemplifies a robust patent strategy in South Korea’s pharmaceutical patent landscape. Its claims’ breadth and scope serve as a barrier to entry for competitors and reinforce the innovator's market position. However, ongoing patent filings and emerging similar technologies emphasize the importance of continuous patent landscape monitoring and strategic IP management.
Key Takeaways
- The patent's claims are structured to secure broad protective coverage over specific compounds, their uses, and methods, which is essential to safeguard commercial interests.
- The scope of the patent must be continually evaluated against existing patents and emerging filings to identify potential infringement risks and opportunities for licensing.
- Stakeholders should leverage this patent to strengthen R&D positions, facilitate licensing negotiations, or develop non-infringing innovations.
- The patent landscape indicates a competitive environment; thus, strategic patenting beyond the initial filings is vital for maintaining a technological edge.
- Continuous monitoring of international equivalents and patent status is crucial to support global commercialization and enforcement.
FAQs
1. What is the core invention protected by KR101748892?
It generally covers a novel pharmaceutical compound, its synthesis method, and therapeutic use in treating specific diseases. The exact chemical structure and use claims define the patent's scope.
2. How does KR101748892 compare to international patents?
The patent may have equivalents or similar filings worldwide. It often complements international patent families, but specific claims’ scope and breadth may vary by jurisdiction.
3. Can the patent be challenged or invalidated?
Yes. Challenges can arise based on prior art, lack of novelty, or inventive step. Its strength depends on the prosecution history and evidence supporting the claims.
4. Does this patent cover all possible derivatives of the compound?
Not necessarily. The breadth depends on claim language; narrower claims limit protection, while broader claims may be more vulnerable to validity challenges.
5. What are the strategic implications for companies holding this patent?
They can block competitors, license the technology, or develop improved formulations within the patent's scope, strengthening their market position.
References
[1] South Korea Intellectual Property Office (KIPO). Patent KR101748892.
[2] World Intellectual Property Organization (WIPO). Patent family data.
[3] Drafting and prosecution strategies for pharmaceutical patents.
[4] Comparative analysis of international patent landscapes in pharmaceuticals.
